Biotech Values

[genisi]

The criteria in PROVE 1 was different - patients not achieving RVR in PROVE 1 were automatically counted as treatment failures in the 12+12 arm and received 48 weeks of total therapy. In PROVE 2, non RVR patients were allowed to stop treatment at 24 weeks so non RVR patients were counted.